7/22/2023 0 Comments Signal vault successThis release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions, particularly in the life sciences industry. Veeva is headquartered in the San Francisco Bay Area, with offices throughout North America, Europe, Asia, and Latin America. Committed to innovation, product excellence, and customer success, Veeva serves more than 850 customers, ranging from the world's largest pharmaceutical companies to emerging biotechs. is the leader in cloud-based software for the global life sciences industry. Register and view the agenda at /SafetyForum.įor more on Veeva Vault Signal, visit: /eu/VaultSignalĬonnect with Veeva on LinkedIn: /company/veeva-systems The event is open to Veeva customers and invited guests. Learn more about Vault Signal at the upcoming virtual Veeva Safety Forum, 19 May. Vault Signal is planned for availability in the U.S. Vault Signal, Vault Safety.AI, Vault Safety, and Vault SafetyDocs are part of the Veeva Vault Safety Suite to manage end-to-end drug safety processes. Read today’s press release to learn more. In other news today, Veeva announced Veeva Vault Product Surveillance, a new cloud application for medical device and diagnostics to simplify and standardize the postmarket surveillance process. “Veeva Vault Signal will give organizations the full visibility and traceability they need to drive compliance in patient safety.” “Veeva is delivering a modern approach to signal management that will speed up how pharmacovigilance teams analyze data, detect and evaluate signals, and perform risk mitigation,” said Kelly Traverso, vice president of safety strategy at Veeva. Vault Signal is easily tailored to align with every signal management process and meet the needs of any business, from large pharmaceutical companies to emerging biotechs. Pharmacovigilance teams can more readily identify and manage signals, improving future risk mitigation. Vault Signal analyzes and segments adverse event data from customers’ safety databases and external global health authorities. “Streamlining adverse reaction data, signal analysis, and action with one platform will make safety risk management simpler and faster, as well as free up my group’s resources.” “Veeva Vault Signal is welcome news for companies looking for an efficient, one-stop solution for drug safety,” said Marc Morris, vice president, safety and pharmacovigilance at Apellis Pharmaceuticals. ![]() Together with Vault Safety, Vault SafetyDocs, and Vault Safety.AI, Veeva offers the only comprehensive suite of cloud applications on a single cloud platform to manage the drug safety lifecycle – from case intake to signal detection and risk management planning. ![]() Vault Signal unifies signal management processes so pharmacovigilance teams can easily manage safety signals with greater visibility across the entire signal workflow. The results indicate that the improved scheme is able to improve the performance of Fuzzy Vault and thus the success rate of authentication or key distribution between genuine nodes of a BSN.Veeva Systems (NYSE: VEEV) today announced Veeva Vault Signal, the industry’s first solution that seamlessly manages signals from identification through risk evaluation and mitigation. An improved scheme with the deployment of Fuzzy Vault and error correcting coding was then proposed, followed by simulation analysis. In this study, the PSKA scheme was firstly analyzed and evaluated for its practical usage in terms of fuzzy performance, the result of which indicates that the scheme is not as good as claimed. Among them, a method named as Physiological Signal based Key Agreement (PSKA) was proposed to use frequency-domain information of physiological signals together with Fuzzy Vault scheme to secure key distribution in BSN. A family of biometrics based security methods has been proposed in the last several years, where the bio-information derived from physiological signals is used as entity identifiers (EIs) for multiple security purposes, including node recognition and keying material protection. The security of Body Sensor Network (BSN) has become a vital concern, as the massive development of BSN applications in healthcare.
0 Comments
Leave a Reply. |